The Global CAR T Cell Therapy Market Is Expected to Be Valued at US$ 8.5 Billion: Novartis International AG, Kite Pharma Inc., Bellicum Pharmaceutical, Celgene Corp.
The growing prevalence of cancer across the world, technological advancement for advanced & reliable treatment for cancer, growing pharmaceutical industry, and rise in the number of cell therapy clinical studies are driving the growth of the global CAR T cell therapy market.
View full press release